-
The manufacturer of the abortion pill mifepristone (Mifeprex, Danco Laboratories; New York City) has revised the safety information for the drugs label and issued a letter to health care providers in light of five deaths from serious bacterial infection and sepsis following use of the medication abortion regimen.
-
No doubt you have scanned news reports of a recent study of male circumcision, used as an HIV prevention intervention, which resulted in dramatic reduction in HIV incidence among circumcised men.1 But does the news translate into an immediate change in public health policy?
-
Take a look at www.trichomoniasis.net, the first comprehensive web site to focus on the sexually transmitted disease (STD) trichomoniasis.
-
How do you initiate mini-pills in a lactating woman who specifies such pill use for contraception?
-
If emergency contraception (EC) is made available over the counter (OTC) in the United States, will it lead to more unprotected sex and increased use? Results from a just-published analysis of British use of the drug indicates that it will not.
-
Has your office telephone been ringing with questions from patients following a recent media report that the death rate for the transdermal contraceptive (Ortho Evra, Ortho-McNeil Pharmaceutical, Raritan, NJ) is three times that expected for oral contraceptives?
-
Vlachopoulos et al studied 17 healthy non-smoking adults (mean age 29), who were free from vasculopathies such as diabetes, hyperlipidemia, or family history of premature vascular disease.
-
-
Promising New Weight Loss Drug?; Treating Shift-Work Disorder; Another Flu Vaccine Shortage?; FDA Actions
-
There is a strong tendency today to continue to hospitalize patients diagnosed to have arrested preterm labor.